Literature DB >> 10704704

The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer.

M Chen1, G L Jiang, X L Fu, L J Wang, H Qian, G Y Chen, S Zhao, T F Liu.   

Abstract

PURPOSE: A retrospective study was carried out to evaluate the impact of overall treatment time (OTT) on the results of radiation therapy for non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: From Jan. 1990 to Dec. 1996, 256 patients with stages I-IIIb NSCLC entered this analysis. All patients received definitive radiotherapy. Biologically effective dose (BED) was used to standardize the irradiation effects. The correlation between OTT and local progression-free survival was analyzed by linear-regression and Cox proportional hazard models. The prognostic variables for survival and distant metastasis were also briefly studied.
RESULTS: OTT had been shortened in 64 patients because of an accelerated hyperfractioned irradiation, while OTT was prolonged i n 114 patients due to interruptions of irradiation courses. The main ca uses of interruption were machine breakdown or delayed preparations of c errobend block for boost fields (55%), holidays (11%) and treatment toxi city and side effects (34%). Patients tre ated with prolonged OTT (> 45 days) had significant poorer local progression-free survival than whom with OTT of </=45 days, 1, 3 and 5 year actuarial local progression-free survivals being 49, 17 and 15% for the former, and 74, 35 and 25% for the latter, respectively (P<0.001). BED-T that contained the factor of OTT correlated directly to local controls, which implied that BED-T represented radiobiological effects accurately, in other words, OTT had played a role in determining the radiobiological effects. Linear-regression on 103 cases treated with BED of 80-85 Gy(10) showed that 3 year local progression-free survival decreased by 9% per week with prolongation of OTT, or vice versa it increased by 9% per week with shortening OTT in an OTT range of 30-76 days. Cox multivariate analyses confirmed that OTT was an independent prognostic factor for local controls.
CONCLUSION: OTT may have played an important role in determining local controls in radiotherapy for NSCLC. One should always keep in mind to make the OTT as short as possible, provided the patients can tolerate it, and to reduce irradiation interruptions for whatever reasons to a minimum.

Entities:  

Mesh:

Year:  2000        PMID: 10704704     DOI: 10.1016/s0169-5002(99)00113-0

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  14 in total

1.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

Review 2.  Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Authors:  Rosemary Stevens; Fergus Macbeth; Elizabeth Toy; Bernadette Coles; Jason F Lester
Journal:  Cochrane Database Syst Rev       Date:  2015-01-14

3.  Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.

Authors:  Matthew P Deek; Sinae Kim; Inaya Ahmed; Bruno S Fang; Wei Zou; Jyoti Malhotra; Joseph Aisner; Salma K Jabbour
Journal:  Am J Clin Oncol       Date:  2018-04       Impact factor: 2.339

Review 4.  Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Authors:  Muhammad M Fareed; Rizwan Ishtiaq; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2018-03-12

5.  The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer.

Authors:  Talha Shaikh; Elizabeth A Handorf; Colin T Murphy; Ranee Mehra; John A Ridge; Thomas J Galloway
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-06       Impact factor: 7.038

Review 6.  [Delays and treatment interruptions: difficulties in administering radiotherapy in an ideal time-period].

Authors:  Carmen González San Segundo; Felipe A Calvo Manuel; Juan Antonio Santos Miranda
Journal:  Clin Transl Oncol       Date:  2005-03       Impact factor: 3.405

7.  Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.

Authors:  Matthew P Deek; Brian Benenati; Sinae Kim; Ting Chen; Inaya Ahmed; Wei Zou; Joseph Aisner; Salma K Jabbour
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-25       Impact factor: 7.038

8.  The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer.

Authors:  Bing Xia; Gui-Yuan Chen; Xu-Wei Cai; Jian-Dong Zhao; Huan-Jun Yang; Min Fan; Kuai-Le Zhao; Xiao-Long Fu
Journal:  Radiat Oncol       Date:  2011-05-19       Impact factor: 3.481

9.  Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies.

Authors:  Xiao Hu; Bing Xia; Yong Bao; Yu-Jin Xu; Jin Wang; Hong-Lian Ma; Fang Peng; Ying Jin; Min Fang; Hua-Rong Tang; Meng-Yuan Chen; Bai-Qiang Dong; Jia-Nan Jin; Xiao-Long Fu; Ming Chen
Journal:  Strahlenther Onkol       Date:  2019-11-29       Impact factor: 3.621

Review 10.  Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer.

Authors:  Jennifer Lewis; Erin A Gillaspie; Evan C Osmundson; Leora Horn
Journal:  Front Oncol       Date:  2018-01-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.